These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35090003)

  • 1. An International Survey of Glucose-6-Phosphate Dehydrogenase Laboratory Reporting Practices.
    Genzen JR; Nwosu A; Long T; Murphy H; Alter DN
    Arch Pathol Lab Med; 2022 Jan; ():. PubMed ID: 35090003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An International Survey of Glucose-6-Phosphate Dehydrogenase Laboratory Reporting Practices: Implications for Tafenoquine Eligibility Assessment.
    Genzen JR; Nwosu A; Long T; Murphy H; Alter DN
    Arch Pathol Lab Med; 2022 Jan; ():. PubMed ID: 35089991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Percentage-Based Reporting of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzymatic Activity.
    Calvaresi EC; Genzen JR
    Am J Clin Pathol; 2020 Jul; 154(2):248-254. PubMed ID: 32405645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tafenoquine and G6PD: a primer for clinicians.
    Chu CS; Freedman DO
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30941413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (
    Rueangweerayut R; Bancone G; Harrell EJ; Beelen AP; Kongpatanakul S; Möhrle JJ; Rousell V; Mohamed K; Qureshi A; Narayan S; Yubon N; Miller A; Nosten FH; Luzzatto L; Duparc S; Kleim JP; Green JA
    Am J Trop Med Hyg; 2017 Sep; 97(3):702-711. PubMed ID: 28749773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rajapakse S; Rodrigo C; Fernando SD
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreservation of glucose-6-phosphate dehydrogenase activity inside red blood cells: developing a specimen repository in support of development and evaluation of glucose-6-phosphate dehydrogenase deficiency tests.
    Kahn M; LaRue N; Bansil P; Kalnoky M; McGray S; Domingo GJ
    Malar J; 2013 Aug; 12():286. PubMed ID: 23961874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
    Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
    Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
    Pfeffer DA; Ley B; Howes RE; Adu P; Alam MS; Bansil P; Boum Y; Brito M; Charoenkwan P; Clements A; Cui L; Deng Z; Egesie OJ; Espino FE; von Fricken ME; Hamid MMA; He Y; Henriques G; Khan WA; Khim N; Kim S; Lacerda M; Lon C; Mekuria AH; Menard D; Monteiro W; Nosten F; Oo NN; Pal S; Palasuwan D; Parikh S; Pitaloka Pasaribu A; Poespoprodjo JR; Price DJ; Roca-Feltrer A; Roh ME; Saunders DL; Spring MD; Sutanto I; Thriemer K; Weppelmann TA; von Seidlein L; Satyagraha AW; Bancone G; Domingo GJ; Price RN
    PLoS Med; 2020 May; 17(5):e1003084. PubMed ID: 32407380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.
    Chamchoy K; Sudsumrit S; Thita T; Krudsood S; Patrapuvich R; Boonyuen U
    PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010986. PubMed ID: 36508454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
    Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M
    Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usability of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency: a multi-country assessment of test label comprehension and results interpretation.
    Gerth-Guyette E; Adissu W; Brito M; Garbin E; Macedo M; Sharma A; Das S; Lacerda MVG; Pereira D; Talukdar A; Yilma D; Pal S; Zobrist S; Domingo GJ
    Malar J; 2021 Jul; 20(1):307. PubMed ID: 34238299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
    Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
    Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria.
    Ley B; Alam MS; Satyagraha AW; Phru CS; Thriemer K; Tadesse D; Shibiru T; Hailu A; Kibria MG; Hossain MS; Rahmat H; Poespoprodjo JR; Khan WA; Simpson JA; Price RN
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010406. PubMed ID: 35544453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
    Anderle A; Bancone G; Domingo GJ; Gerth-Guyette E; Pal S; Satyagraha AW
    Int J Neonatal Screen; 2018; 4(4):34. PubMed ID: 31709308
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.